For research and educational purposes only. Not medical advice.
5-amino-1MQ Reference
Educational, not medical advice reference for 5-amino-1MQ: Metabolic, Fat Loss; regulatory status, evidence posture, source review, and schedule notes. Also…
Reference summary
Published work is preclinical, focused on NNMT-inhibition mechanisms and rodent diet-induced-obesity models. There is no published human clinical program at the time of review.
- Categories
- Metabolic, Fat Loss
- Aliases
- 5-amino-1-methylquinolinium, NNMT inhibitor, Non-peptide small molecule
- Evidence posture
- preclinical — Preclinical rodent data only. There is no published human clinical program for 5-amino-1MQ, and NNMT inhibition as a weight-loss strategy has not been validated in humans.
- Regulatory status
- No FDA-approved 5-amino-1MQ drug label. 5-amino-1MQ is a non-peptide small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) studied in rodent models of diet-induced obesity.
- Content review status
- research reference